This is the authors' abstract. We don't add key points for this paper.
The aim of our review was to evaluate the perspectives of new therapeutic approaches in comorbid depressive and somatic disorders based on common pathological mechanisms and their genetic risk factors. Literature analysis showed that depression was a complex heterogeneous condition associated with significant prevalence of metabolic, cardiovascular and immune disturbances. The understanding of common molecular mechanisms of risks and course of abovementioned disorders could provide a new strategy for early diagnosis and therapeutic optimization and give the opportunity of 'targeted' approach to different pathological elements.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Рукавишников et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: